Carmot Therapeutics
Carmot Therapeutics is a clinical-stage biotechnology company focused on discovering and developing innovative therapies for metabolic diseases, including obesity and diabetes. Utilizing its proprietary Chemotype Evolution platform, Carmot Therapeutics accelerates the identification of novel drug candidates with improved efficacy and safety profiles. The company’s pipeline features multiple investigational treatments targeting key metabolic pathways, aiming to address significant unmet medical needs. By leveraging advanced research and a robust scientific approach, Carmot Therapeutics is committed to transforming the treatment landscape for patients affected by metabolic disorders. The company collaborates with industry partners to advance its mission of delivering impactful, next-generation therapeutics to improve patient outcomes worldwide.
